Dr. Valerie Arkoosh, President of the National Physicians Alliance

This week, Mark and Margaret speak with Dr. Valerie Arkoosh, President of the National Physicians Alliance, an organization founded to restore trust in the medical profession by eliminating conflicts of interest. Dr. Arkoosh discusses their “Un-Branded Doctor” initiative which urges physicians to refuse payments of any kind from the pharmaceutical and medical device industry, and talks about the organization’s “Good Stewardship” program which calls for doctors and patients to reduce costly and unnecessary tests.

(Music)

Mark Masselli: This is Conversations on Health Care. I am Mark Masselli.

Margaret Flinter: And I am Margaret Flinter.

Mark Masselli: Margaret, it seems like we have a three-round heavyweight fight
going on in Washington around the Affordable Care Act. Round one went to the
administration with the passage of the Affordable Care Act but round two has
seemed to go to those who were in opposition to the Affordable Care Act. A
recent survey in the New York Times lays out in great detail that people seem to
be quite opposed to many elements of the act. It’s quite surprising.

Margaret Flinter: I was really surprised by the number of folks who thought some
or all of the act ought to be repealed, and of course, trying to identify which part
of the some is disturbing to people is a question. And at the same time Mark,
you probably noticed, some of the innovations continued to roll out. And I noticed
right here in Connecticut, the State Medical Society was successful on being
funded to form a co-op. So when we see doctors organizing cooperatives to
deliver care and create insurance plans that’s kind of unusual.

Mark Masselli: It is, and yet troubling that perhaps the administration missed the
larger battle that was going on and had put all of its emphasis on the Supreme
Court but this does not bode well. And I know you are off to the White House
with the meeting of nurses to really hear from the administration about their
plans. So I just am wondering what the administration is planning to do if things
go in the wrong direction for their plan.

Margaret Flinter: Well Mark, I think many people have said there is no Plan B out
there with a different way to approach the problems of lack of insurance and
spiraling cost in this country. But I suspect the administration is going to be
looking for ways to continue transformations and innovations and an expansion
in care to underserved populations no matter what happens.

Mark Masselli: I think you are right. Reform is coming. And not just in
Washington, there is an encouraging movement underway that will help reduce
waste of our limited medical resources. The Good Stewardship Program
launched by the National Physicians Alliance is seeking to scale back 45
commonly over-prescribed medical tests that add to health care cost while being
of no particular benefit to patients and can actually cause harm.

Margaret Flinter: That’s the kind of thing if it was imposed from outside of
medicine people would see it as rationing; from within, it’s do no harm.

Mark Masselli: Our guest today is Dr. Valerie Arkoosh, President of the National
Physicians Alliance. And she will be telling us about that and other programs the
organization is promoting to improve integrity in the medical profession. It’s an
ambitious program.

Margaret Flinter: But no matter what the topic, you can find all of our shows by
Googling CHC Radio.

Mark Masselli: And as always, if you have comments, email us at
www.chcradio.com . We love to hear from you. We will get to Dr Arkoosh in just a
moment but first here is our producer Marianne O’Hare with this week’s Headline
News.

(Music)

Marianne O’Hare: I am Marianne O’Hare with this Headline News. The
Supreme Court’s decision on the Affordable Care Act is probably the most
anticipated piece of business dominating the federal government right now. And
the decision is expected by the end of this month on what, if any of the health
care law will be overturned by the High Court. And the stakes are high, not just
for politicians on both sides of the aisle and the issue but state governments,
nation’s hospitals, doctors, insurers and patients as well. Most analysts view the
individual mandate as the most vulnerable aspect of the law.

Another provision could also be challenged by the court expanding Medicaid to
include coverage of more uninsured families living near the poverty line. It would
also put states in a precarious position trying to adhere to covering the
uninsured. And while the nation’s insurers are saying they will move forward, at
least some of them, with reform measures no matter what the Supreme Court
decides, UnitedHealthcare, the nation’s largest insurer says it will continue with
several provisions outlined in the Affordable Care Act. It will let young adults stay
on their parents’ plan until the age of 26, won’t charge co-pays for preventive
care visits and will streamline the appeals process if a customers wants to
challenge denial of a benefit.

And you want to quit smoking, grab an orange, a carrot or maybe a piece of
celery. Study out of the University at buffalo showed those who had higher rates
of fruit and vegetable consumption were three times more likely to quit smoking
and three times more likely to remain smoke-free after a year, another good
reason to strive for five. I am Marianne O’Hare with this Headline News.

(Music)

Mark Masselli: Today, we are speaking with Dr .Valerie Arkoosh, President of the
National Physicians Alliance, an organization founded to restore trust in the
medical profession by eliminating conflicts of interest. Approximately 20,000

member physicians are urged to refuse expecting monetary compensation from a
corporate interest in health care. The National Physicians Alliance is dedicated
to universal affordable health care for all citizens. Dr. Arkoosh is a Professor of
Anesthesiology and Obstetrics at the Perelman School of Medicine at the
University of Pennsylvania. Welcome to Conversations on Health Care.

Dr. Valerie Arkoosh: Thank you. It’s really a pleasure to be here.

Mark Masselli: Now the National Physicians Alliance is a relatively new
organization founded in 2005 with a goal of restoring trust to the medical
community, which you say has eroded significantly in years due to the influence
of pharmaceutical and biomedical companies. Can you paint that picture for us
of just how far reaching is this practice and how deeply has it impacted the
medical profession?

Dr. Valerie Arkoosh: Well, it’s a very far-reaching practice. And I am sure that all
of your listeners can think about the last time they went to their doctor’s office
and what they saw sitting on the table. The pen that the doctor was using and
many, many times, all the pads of paper are branded with various drug company
names or various drugs. The extent of this is enormous. I have some data from
2008 where it was found that the pharmaceutical industry spent $20 billion that
year on all of these marketing efforts to physicians. And the reason this is so
critical is that any gift, even a pen, creates a sense of indebtedness on the part of
the recipient. And so the goal of these gifts is very simply to get doctors to
prescribe the newer, more expensive, no generic equivalent type of drugs. And
for the patient, that may be exactly the drug that they need but it also may be a
drug that is not necessary and they could do just as fine with a drug that’s less
expensive and that we have more experience with in terms of safety.

Margaret Flinter: Dr. Arkoosh, in response to this issue, the National Physicians
Alliance has developed the Unbranded Doctor program, which urges the
physicians to announce the gifts and the lecture fees in marketing of educational
events that can undermine objectivity and integrity, and even the New England
Journal of Medicine has lauded the program as unmasking a serious problem.
So the problem sounds pretty pervasive and I understand you have been holding
Unbranded Doctor National Grand Rounds in which you share methods for
confronting the issue, which helps people avoid the conflict of interests in medical
practices and even in medical schools. Tell us about how these grand rounds
have been going. What’s the response and what do you hope they will
accomplish?

Dr. Valerie Arkoosh: Most divisions would tell you that they are not influenced by
the pharmaceutical gifts and yet, there is an enormous amount of data that finds
just the opposite, that doctors actually are influenced by this marketing. And it
would be hard to believe that the pharmaceutical industry would spend $20 billion
a year marketing these things to doctors if they weren’t influenced. And so really,

step number one is education. And we are rolling out, over the next three years,
a series of 12 of these grand rounds, and we are doing this in partnership with
few charitable trusts, Community Catalyst and the American Medical Student
Association in an effort to reach medical students as well as the public.

Mark Masselli: You know, we recently had Daniel Wilson from the American
Board of Internal Medicine on the show, talking about the Choosing Wisely
Campaign, which urges medical disciplines and patients to reduce the number of
unnecessary and expensive tests they order. Now, that program is based really
on National Physicians Alliance Good Stewardship Project, which brought
together clinicians from a number of specialties to access areas where finite
health resources were being wasted often at no benefit to the patient. So, have
you been able to assess the impact that the Choosing Wisely Campaign is
having on the medical and patient community?

Dr. Valerie Arkoosh: Well what I am sensing is a lot of optimism. The National
Physicians Alliance Project went public about a year ago. And we published
three lists of five things. We call them our top 5 lists, one was in internal
medicine, one is family medicine and one in pediatrics, of tests or procedures
that have no evidence that they provide any benefit to patients, and in fact, can
even cause harm to patients. For instance, giving a child antibiotics for an ear
infection on the first day of the ear infection, that can often cause problems down
the road. So, it’s things like that that are on the list. And it was very, very well-
received. That study or that work was actually funded by the American Board of
Internal Medicine Foundation and because that was so well-received, it has
morphed into this much bigger project called Choosing Wisely.

I recently attended a meeting called Avoiding Avoidable Care with about a 100
other physicians and it’s really fantastic to see what’s going on around this work.
Physicians are eager I think to embrace evidence-based guidelines that show
clearly improved quality of care for their patients. It’s so hard for a doctor to say
no when a patient’s asking for something. And I think that doctors feel bolstered
by the fact that all of their specialty organizations are now saying, “You know
what, it’s okay to say no to these things because there is just no evidence that
they work”. So I am very excited about it and I think most of my colleagues are
as well.

Margaret Flinter: Well Dr. Arkoosh, I think we share your optimism on that and
also the realization we are up against several decades of tradition and traditions
die hard. And we wonder as we all look at the issue of cost containment what
other initiatives are you planning, what else is in the pipeline that you see as
achieving this aim of both improving care and quality but also controlling cost and
eliminating waste?

Dr. Valerie Arkoosh: Well, in addition to all the top five work, we are of course
very invested in reducing the influence of drug company marketing on clinical

decision making as well as medical device marketing on clinical decision making.
And kind of hand and glove with that is support for the new Patient-Centered
Outcomes Research Institute, which people call, take the initials and call PCORI.
This institute will help fund research that will provide unbiased assessments or
comparisons between different drugs, different medical procedures, different
devices. And as that work starts to roll out, we will certainly do our best to help
disseminate that to our members so that doctors have more unbiased information
about drugs and devices. A lot of the information that we have right now is
actually from studies that are funded by the pharmaceutical company making the
drug or the device company making the drug, and obviously, they have a pretty
big stake in the outcome. So we are glad that there is now going to be an
independent body doing some of that work.

And then another two other very important areas; one is prevention. And what
we are seeing under the Affordable Care Act is a tremendous focus on making
sure that patients get proven preventive treatments to keep them healthy in the
first place so that we turn ourselves into truly more of a health care system rather
than our current sick care system where we wait for people to get sick before we
do anything. And that I think can at least keep people healthier and working and
being functioning members of our community for a longer time. And then finally,
we have been following very closely the various payment reforms that are also
part of the Affordable Care Act. And these payment reforms will start to move us
away from our current system, where physicians are paid for the quantity of care
that they provide, and they will start to move us toward a payment paradigm,
where we get reimbursed for the quality of care that we provide. And I think right
there, you will start to see a change in cost.

Mark Masselli: We are speaking today with Dr. Valerie Arkoosh, President of the
National Physicians Alliance, seeking to eliminate conflicts of interest in the
medical profession by urging physicians to stop taking financial compensation
from pharmaceutical and biomedical companies, which can then impact the
physician’s integrity and objectivity. Now, you were just talking about the
Affordable Care Act. Tell us a little bit about your position around the challenge
that's been made to the Affordable Care Act. Have you been active in filing a
brief to the court on the Affordable Care Act challenge?

Dr. Valerie Arkoosh: Yes, we were. Actually, we signed on to one of the Amicus
brief. And we feel that the law should be upheld in its entirety. The law has a
number of provisions that will make health insurance more secure for those that
have it and also overtime less expensive. And it also reduces discrimination by
insurance companies against women and also people with pre-existing
conditions. Women have historically been charged higher premiums than men,
even when they were beyond child-bearing years. And very importantly, and very
popular, is that insurance companies now must cover pre-existing conditions in
children and would also have to do so in adults in January of 2014. So I think
what's important and what’s been kind of lost in the argument around this is that

the individual mandate, which is the provision that says everyone in the country
must take personal responsibility and have health insurance, is important in order
to have coverage of pre-existing conditions. A lot of people would just simply not
buy health insurance when they were healthy; they would wait until they got sick
because they know they would be covered. And under that scenario, very few
healthy people would probably own insurance. And so, the way that insurance
works is that we have a large group of people, a small percentage of whom are
sick and actually using their insurance and they are being covered by all the
healthy people who aren’t, and then when a different person gets sick, there will
be other healthy people to cover them. So if we are going to ask health
insurance companies, or demand actually, that they cover pre-existing
conditions, really just about everybody has to be in the insurance pool in order for
that to work. There has certainly been a number of judges on both sides, both
conservative, historically conservative judges, as well as more liberal judges, that
have found it to be constitutional. So we will see what the Supreme Court says.

Margaret Flinter: So Dr. Arkoosh, let me ask you this. Certainly one of the
central missions of the National Physicians Alliance is returning the practice of
medicine to its foundations and service and integrity and efficacy with the patient
but I would be curios about your organizing approach to this work. You have a
national organization and you have done some remarkable work nationally but
ultimately this is really done on the ground and locally organized in communities
where physicians organize. How are you doing that? How are you working at
the local level across the country?

Dr. Valerie Arkoosh: Well I think one of the most important differences about the
National Physicians Alliance is that we are not a typical trade association, we are
actually a 501(c)(3) charitable organization. And as part of our mission, when we
think about issue areas that we are going to take on, we start by saying, how is
this going to affect patients. And historically, most trade associations tend to look
at an issue and ask the question, “How will this affect doctors?: And we work, as
you said, mostly on national issues but we are very open to issues that bubble up
locally and we encourage our physicians to become specifically engaged in their
communities to work on those issues.

We also work a lot with other non-physician coalition partners. A lot of it’s around
producing educational materials. For instance, we just produced a wonderful
brochure with the National Women's Law Center about all the new benefits for
women under the Affordable Care Act. So it really depends on what the issue is
but we love working with organizations on the ground in different states or cities
on issues that people care about locally. I am really looking forward to the day
when if we have a patient sent to us from another hospital for instance maybe in
the middle of the night, we can access their records at their other hospital. I do
obstetrics mostly. I am an anesthesiologist that works on the labor floor and the
pregnant woman calls 911, the ambulance by law here has to take her to the
closest hospital that does obstetrics. And so we have to repeat everything. Even

though that patient has had all of her prenatal care, we have to repeat all of her
blood work and ultrasound and all those things because we just can’t access
those records in the middle of the night.

Margaret Flinter: It’s a big challenge. How do you think they are going to be able
to step up to the plate and begin to take on some of this work without bias from
the industries?

Dr. Valerie Arkoosh: Well I think what we are going to see is since the
development of electronic medical records, organizations that are historically not
sites of research like some of these large multi-specialty group practices for
instance that may have a couple hundred physicians, they are going to be able to
use those electronic medical records very effectively to look at the patients that
they are actually caring for and seeing how various treatment algorithms work in
their patients. That will probably still stay in the academic health centers where
that work has been historically done. But what we will see out in some of these
bigger group practices is this work on what I would call more outcomes research
where they are able to take their own large groups of patients and look at how
various treatment options work.

Mark Masselli: You know I want to ask a question about the pharmaceutical and
biomedical companies. Have you laid out for the pharmaceutical and biomedical
companies a set of principles that they should all act by, that aligns with the
NPA’s philosophy, and if so, could you talk to us about its development?

Dr. Valerie Arkoosh: The Association of Academic Medical Centers has a set of
documents about the relationship between an academic health center and
pharmaceutical industries or device companies that we endorse. And the
American Board of Internal Medicine Foundation has a document called the
Physician Charter, and one of the components of that talks about transparency
and integrity and practice and the importance of making sure that we position,
take responsibility for careful use of finite resources. And so we have really filled
what we think was a different hole, which was to help doctors understand how
important these issues are. And so we urge our members and really all
physicians not to let the drug rep come in with lunch, and there really is no free
lunch, and not to accept the pens and the pads of paper and to be very, very
thoughtful and careful about going to a continuing medical education conference
that’s sponsored by a pharmaceutical or a device company because often times
the information that’s presented at a conference like that may not be free of bias.

Margaret Flinter: Dr. Arkoosh, we like to ask all of our guests this final question.
When you look around the country, and the world, what do you see in terms of
innovation that our listeners at Conversations should be keeping an eye on?

Dr. Valerie Arkoosh: The innovations that I am really excited about are those that
are going to help doctors and patients to recapture that most fundamental

component of healing, which is simply time to talk to each other. And I think that
as we see some of the various reforms rolling into place here, doctors are going
to be able to reconfigure their practices so that they can spend more time with
the patients that they need to spend time with and use other means to interface
with patients that just need a quick lab result or just have a very quick question
that another member of the team can answer, and I am really excited about that.

Mark Masselli: We have been speaking today with Dr Valerie Arkoosh, President
of the National Physicians Alliance, an organization dedicated to providing quality
affordable health care for all, and restoring integrity to the medical profession.
Doctor, thank you so much for joining us today on Conversations.

Dr. Valerie Arkoosh: Thank you. It was a real pleasure.

(Music)

Mark Masselli: At Conversations on Health Care, we want our audience to be
truly in the know when it comes to the facts about health care reform and policy.
Lori Robertson is an award-winning journalist and managing editor of
FactCheck.org, a non-partisan, nonprofit consumer advocate for voters that aim
to reduce the level of deception in US politics. Lori, what have you got for us this
week?

Lori Robertson: Well, Mark and Margaret, we have seen a lot of viral claims
about the federal health care law. For instance, our readers recently asked us
about an email that was reminiscent of the bogus death panels claim. I am sure
you remember those. This particular email said that an emergency room doctor
in Tennessee had said that the health care law was currently denying dialysis to
some Medicare patients and that the law will deny major medical procedures to
anyone over age 75, beginning in 2013. But the email was a complete fraud.
The name of an actual doctor or the real life person who exists at a Tennessee
hospital is given in the email but a spokesman for the hospital says that the
doctor never said the things that are attributed to her, and the spokesman said
the claims in the email just aren’t true. The doctor said that there was a guest in
her home, who fabricated the account and she was very upset about it. The
spokesman said from the hospital’s point of view, patients’ access to care has
been increased because of the law, if there had been any effect at all. We have
said many times at FactCheck that the law doesn’t create any death panels or
ethics panels as this emails says, nor is there any mention of any provision at all
that would specifically affect those over age 75 so this is just a complete
fabrication. We recommend extreme skepticism when it comes to viral emails.
It’s incredibly rare that we find an email that’s actually correct. We recommend
deleting them not forwarding them. And that’s my fact check for this week. I am
Lori Robertson, managing editor of FactCheck.org.

Margaret Flinter: FactCheck.org is committed to factual accuracy from the
country’s major political players and is a project of the Annenberg Public Policy
Center at the University of Pennsylvania. If you have a fact that you would like
checked, email us www.chcradio.com , we will have FactCheck.org’s Lori
Robertson check it out for you here on Conversations on Health Care.

(Music)

Mark Masselli: Each week, Conversations highlights a bright idea about how to
make wellness a part of our communities and everyday lives. Global maternal
death rates have declined since 1990 however, each year across the globe, more
than three million newborns die and 360,000 women die in childbirth as well,
often from preventable causes. A year ago, Secretary of State, Hillary Clinton
announced the launch of Mobile Alliance for Maternal Action or MAMA, founded
along with the United Nations Foundation and the mHealth Alliance linking the
vastly expanding mobile communications network with health care workers and
expectant mothers in impoverished areas of the world. While many women in
these regions don't always have direct access to health care, more than one
billion women in low and middle income countries own a mobile phone. MAMA’s
premise was simple; alert expectant mothers with weekly phone messages that
remind them of nutritional and other health advice during their pregnancy and
weekly well baby advice for moms and newborns, the challenge according to
Global Partnership Director Kirsten Gagnaire fine-tuning the message so they
work with the cultural guidelines of each community.

Kirsten Gagnaire: We have a whole set of materials. Our most in-depth right
now is these adaptable messages and basically they are messages that cover
the 42 weeks of pregnancy and the first year of a child’s life and there are
multiple messages for each week.

Mark Masselli: Mothers will receive either text messages or voice messages
sent directly to their phones reminding them of the basic things like bringing
newborns in for vaccinations.

Audio Clip: Baby is due to have some more immunizations this week. Like the
ones he had at three months, these immunizations--

Mark Masselli: And community health workers are kept in the loop as well. The
MAMA program is already being scaled up in Bangladesh, India and South Africa
and is looking to expand to 22 countries within the next couple of years. Using
ubiquitous mobile phone technology to reach isolated expectant mothers,
yielding a better outcome for maternal and infant health, now that’s a bright idea.

(Music)

Margaret Flinter: This is Conversations on Health care. I am Margaret Flinter.

Mark Masselli: And I am Mark Masselli, peace and health.

Conversations on Health Care, broadcast from the campus of Wesleyan
University at WESU, streaming live at www.wesufm.org and brought to you by
the Community Health Center.